Indaptus Therapeutics Inc.

INDP | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.04

+$0.95 (+30.74%)

At close: Sep 22, 2026, 3:59 PM ET

$3.94

-$0.10 (-2.48%)

After-hours: Sep 22, 2026, 7:52 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+30.74%

(1D)

Rating

Updated: Sep 10, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $457.5M

1D Range

2.98 4.06

52W Range

0.92 8.57

Valuation (TTM)

PE -0.57

PB 30.77

EV/EBITDA -21.90

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield -4.3%

SBC Adj. FCF Yield -4.6%

SBC Impact -6.3%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -56.7% | -23.2%

FCF 3Y | 5Y -8.5% | 0.9%

Returns

ROA -128.7%

ROE -302.8%

ROIC -129.9%

Financial Health

Net Cash

$11.55M

Current Ratio 19.48

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Indaptus Therapeutics, Inc. is a biotechnology company operating in the pre-clinical phase, dedicated to developing a range of immunotherapeutic products for the treatment of both cancer and viral inf...

Sector Healthcare

Industry Biotechnology

Employees 5

IPO Date Aug 3, 2015

Website indaptusrx.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.